학술논문
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Document Type
Article
Author
Source
In: Clinical Cancer Research . (Clinical Cancer Research, 2023, 29(22):4564-4574)
Subject
Language
English
ISSN
15573265
10780432
10780432